Nizagara 100mg


IDF Advocacy Center Activity



Print Friendly

Activity Document/Resources

RI - HB 8201 Testimony Final
January 8, 2016

CA - AB 1917 Testimony
January 8, 2016

Testimony for CA AB 2533 - Out Of Network EH
January 8, 2016

NJ SB 1705 Testimony Final
January 8, 2016

NJ AB 2477 Testimony
January 8, 2016

MI HB 5598 Testimony FINAL 6-16-14
January 8, 2016

SB 165 - Testimony from Immune Deficiency Foundation - Specialty Tier
January 8, 2016

IDF support of Nebraska rule change to add SCID
January 8, 2016

Immune Deficiency Foundation support AZ HB 2491 - SCID NBS
January 8, 2016

Immune Deficiency Foundation - support of OR rule change to add SCID
January 8, 2016

Immune Deficiency Foundation - support of HB 7094
January 8, 2016

Immune Deficiency Foundation - support of rule change to add SCID
January 8, 2016

IDF - support of Amendment to Chapter 246-650 rule change to add SCID
January 8, 2016

Letter of Support S 754 Rhode Island FINAL
January 8, 2016

Letter of Support H 5591 Immune Deficiency Foundation
January 8, 2016

Immune Deficiency Foundation - Letter of Support for SR 70
January 8, 2016

Immune Deficiency Foundation - Support for HB 644
January 8, 2016

Immune Deficiency Foundation Letter of Support SB35 - Specialty Tier legislation
January 8, 2016

HB 1015 IDF Testimony 2-21-2013 Step Therapy/Formularies bill
January 8, 2016

Indiana HB 1315 - Testimony on Biosimilars legislation
January 8, 2016

Illinois SB 1934 - Testimony on biosimilars legislation
January 8, 2016

Immune Deficiency Foundation Testimony on SB 149 - Arkansas Biosimilars legislation
January 8, 2016

SB 781 Maryland Biosimilars Testimony
January 8, 2016

IDF Comments to Washington Health Benefit Eschange Advisory committee
January 8, 2016

IDF Comments to Vermont Medicaid and Exchange Advisory Board
January 8, 2016

IDF Comments to Kentucky Health Benefit Exchange on Navigator
January 8, 2016

IDF Comments to DC HRIC Communications Subcommittee
January 8, 2016

IDF Comments to Arkansas Consumer Assistance Advisory Committee
January 8, 2016

American Plasma Users Coalition Comments on Essential Health Benefits Final Proposed Rule 12-21-2012
January 8, 2016

IDF Comments to Cover Oregon Consumer Advisory Committee
January 8, 2016

IDF Comments on Nevada Silver State Health Insruance Exchange
January 8, 2016

IDF Comments on MN Exchange Task Force Guiding Principles
January 8, 2016

FDA Prescription Drug User Fee Act Patient-Focused Drug Development 11-1-12
January 8, 2016

IDF Letter on Maryland Essential Health Benefits- FINAL
January 8, 2016

Local and National Advocacy Support - Journal of Clinical Immunology
January 8, 2016

Request for Co-Sponsors of HR 4209 - Patients' Access to Treatments Act - supported by IDF
January 8, 2016

IDF Comments on Illinois Navigator Program - Health Care Reform Implementation
January 8, 2016

IDF Response to ACA 6-28-12
January 8, 2016

Letter of Support CA AB 1800 6-6-2012 Senate
January 8, 2016

Final APLUS letter on MSM RFI
January 8, 2016

Immune Deficiency Foundation Biosimilars Testimony FDA 5-11-12
January 8, 2016

A-PLUS EHB Comments FINAL 1-30-2012
January 8, 2016

IDF and APLUS letter to Debt Supercommittee Oct 2011
January 8, 2016

IDF Essential Benefits Testimony to HHS 10-20-2011
January 8, 2016

Pharmaceutical Fee Letter of Support 8-9-2011
January 8, 2016

IDF Letter of Support HB 1609 PA Specialty Tier 7-27-2011
January 8, 2016

A-PLUS Letter Medicare Cuts Threat during Debt Ceiling Negotiations
January 8, 2016

A-PLUS IPAB Letter 7-18-2010
January 8, 2016

A-PLUS letter on Biovigilance Public-Private Partnership
January 8, 2016

Letter of Support Nebraska Legislation 2-1-2011
January 8, 2016

The High Cost of Cheaper Prescription Drugs, Op Ed from IDF President Marcia Boyle 1-24-11
January 8, 2016

A-PLUS Testimony to the FDA on Biosmiliars 12-31-10
January 8, 2016

A-PLUS Response to IOM Survey on Essential Benefits 12-6-11
January 8, 2016

IDF President Marcia Boyle Testimony on Biosimilars 11-2-10
January 8, 2016

IDF Letter to Treasury on Orphan Drug Exemption 10-12-10
January 8, 2016

IDF, A-PLUS, & NORD Submit Comments on PCIPs 10-4-10
January 8, 2016

IDF Letter to the IRS and Treasury on 1099 Tax Reporting 9-22-10
January 8, 2016

IDF & A-PLUS Submit Comments on Provisions of Healthcare Reform 8-27-10
January 8, 2016

IDF & A-PLUS Submit Comments on Interim Final Regulations of HCR 8-6-10
January 8, 2016

IDF & A-PLUS Seek to Enhance Safety of Blood Supply 6-9-10
January 8, 2016

MSM Blood Donor Deferral Policy, American Plasma Users Coalition Statement 6-10-10
January 8, 2016

Secretary of HHS Announces Addition of SCID to Newborn Screening Standards 5-25-10
January 8, 2016

Immediate Provisions of Healthcare Reform 3-31-10
January 8, 2016

Timeline for Implementation of the Healthcare Reform Law 3-30-10
January 8, 2016

IDF Praises ACHDNC Recommendation for SCID Screening in Newborns 1-25-10
January 8, 2016

Annual Coverage Limits Changed in Senate Health Care Reform Bill 12-22-09
January 8, 2016

No Annual Limits - Letter to Senators 12-17-09
January 8, 2016

Contact Your Senators! This Could Be Our Last Chance This Year! 12-9-09
January 8, 2016

Kerry Wyden et al. IVIG Amendment 12-8-09
January 8, 2016

Summary of Kerry Wyden et al. IVIG Amendment 12-8-09
January 8, 2016

Kerry Benefits Commission Amendment 9-18-09
January 8, 2016

Joint Letter of Support for Biosimilars 9-16-09
January 8, 2016

Coalition Letter to Rockefeller on Finance Amendment 9-15-09
January 8, 2016

Principles for Health Care Reform and the Rare Disease Community 9-14-09
January 8, 2016

Important Legislation in Minnesota Needs Your Support! 6-12-09
January 8, 2016

Increase Private Health Insurance Lifetime Caps! 6-12-09
January 8, 2016

TX rep remembers David Vetter, boy in the plastic bubble 4-23-09
January 8, 2016

New Bill Offers Medicare Reimbursement Fix for IVIG 4-22-09
January 8, 2016

PIDD Patients Deserve a Normal Life, says Brady 4-22-09
January 8, 2016

Minnesota Bill Amended by Senate Committee 3-22-09
January 8, 2016

Kerry, Alexander Introduce Medicare Patient IVIG Access Act 3-25-09
January 8, 2016

Lisa Aker and Kathy Antilla Hearing Testimony 3-25-09
January 8, 2016

Minnesota patients with rare, life-threatening diseases testify 3-18-09
January 8, 2016

New quality of care bill protects Minnesotans with rare disorder 2-5-09
January 8, 2016

Minnesota Senate Bill S.F. No. 339, as introduced - 86th Legis. Session 1-28-09
January 8, 2016

President Bush Signs Genetic Information Nondiscrimination Act of 2008 5-21-08
January 8, 2016

IDF Applauds Legislation to Improve Patient Access to IVIG Treatment 5-8-08
January 8, 2016

IDF Capitol Hill Day 2008 4-21-08
January 8, 2016

Congress Must Act to Expand Immune Disorder Treatment 12-7-07
January 8, 2016

Utah Medicare patients denied life-saving treatment 12-24-07
January 8, 2016

IDF Comments on CMS Proposed Changes 8-14-07
January 8, 2016

IDF Comments on CMS Coding-Payment for IVIG Add-On Code 8-30-07
January 8, 2016

IDF Applauds Legislation to Improve Access to Immunoglobulin Products 7-28-07
January 8, 2016

Time is Running Out! 7-7-07
January 8, 2016

FluMist Immunization and Primary Immunodeficiency 5-16-07
January 8, 2016

IDF's Request of ACBSA 5-10-07
January 8, 2016

Analysis of Supply, Distribution, Demand & Access Issues of IGIV 5-2-07
January 8, 2016

Bureaucracy to Die For... 3-26-07
January 8, 2016

Office of Inspector General Report on IVIG (2) 12-4-06
January 8, 2016

Office of Inspector General Report on IVIG 11-16-06
January 8, 2016

Attention Medicare Patients and Healthcare Providers 12-8-05
January 8, 2016